Showing 1 - 10 of 35
Recent studies in the tradition of Schmookler have re-emphasised the potential role of demand in stimulating innovation. Here, we reconsider the role of 'home' and 'export' market demand in stimulating manufacturing innovation using comparable panel data for two small open economies - Ireland...
Persistent link: https://www.econbiz.de/10009469145
Persistent link: https://www.econbiz.de/10009474645
Persistent link: https://www.econbiz.de/10009474646
Persistent link: https://www.econbiz.de/10009474647
Globally the biopharmaceutical industry is characterized by strong competition, research-intensive and protracted new product development (NPD) processes, intensive regulation and extensive alliance activity. Policy regimes and operating environments differ markedly, however. Here we examine how...
Persistent link: https://www.econbiz.de/10009428670
ROPER S., YOUTIE J., SHAPIRA P. and FERNANDEZ-RIBAS A. Knowledge, capabilities and manufacturing innovation: a USA-Europe comparison, Regional Studies. This paper presents a comparative analysis of factors contributing to the innovation performance of manufacturing firms in Georgia (USA), Wales...
Persistent link: https://www.econbiz.de/10009468825
In England, publicly supported advice to small firms is organized primarily through the Business Link (BL) network. Using the programme theory underlying this business support, we develop four propositions and test these empirically using data from a new survey of over 3000 English SMEs. We find...
Persistent link: https://www.econbiz.de/10009468857
In this paper, we explore the relationship between aspects of firms' potential absorptive capacity (PACAP) on their involvement in exploratory alliances. Our study is based on survey data from firms in the US and European (the UK, Germany, France and Ireland) biopharmaceutical sectors. We use...
Persistent link: https://www.econbiz.de/10009468879
This paper contributes to the developing literature on complementarities in organizational design. We test for the existence of complementarities in the use of external networking between stages of the innovation process in a sample of UK and German manufacturing plants. Our evidence suggests...
Persistent link: https://www.econbiz.de/10009468904
Globally the biopharmaceutical industry is characterized by strong competition, research-intensive and protracted new product development (NPD) processes, intensive regulation and extensive alliance activity. Policy regimes and operating environments differ markedly, however. Here we examine how...
Persistent link: https://www.econbiz.de/10009468935